Replies to post #271801 on Amarin Corp Plc (AMRN)

[north40000]

#AskDrGottlieb is a site mentioned many times by CNBC-TV yesterday. Ask a question and Dr. Gottlieb will answer.

Fashion a question designed to obtain public exposure of Amarin’s Vascepa as a potential supplement to GILD’s Remdesivir in Corona virus market place, as well as in diabetes and cardiovascular disease market place (predicated on FDA approval of Vascepa and Amarin’s sNDA and expanded label that occurred in mid-December 2019).

Patients with pre-existing CVDs and diabetes are at increased risk of death resulting from Corona virus, as Dr. Gottlieb knows.

Include videos of Dr. Bhatt emphasizing that Vascepa is a game changer in CVD practice. I have many of those videos collected above under “north40000”.

Mention that GILD is using Vascepa in an oncology trial. Results are unknown to us.